Stock listing
NASDAQ:AIMT Aimmune Therapeutics Inc Stock
Follow Aimmune Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:AIMT
$34.49 USD
Close on Oct 13, 2020 · No longer trades
- Lowest – highest close
- $10.26 – $39.55 USDSince Aug 5, 2015 · lowest Jul 7, 2016 · highest Dec 22, 2017
Delisted NASDAQ:AIMT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:AIMT
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Aimmune Therapeutics Inc on 6ix
- Decks
- 4 decks · latest Jun 18, 2019
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (June 2019) | Investor deck | 36 slides | Jun 18, 2019 |
| Corporate Update (November 2018) | Corporate update | 31 slides | Nov 19, 2018 |
| Technical Presentation (February 2018) | Technical | 13 slides | Feb 20, 2018 |
| J.P. Morgan Healthcare Conference January 2017 | Conference | 22 slides | Jan 9, 2017 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Mark Iwicki Other companies: Inhibikase Therapeutics, Inc. (Chief Executive Officer - Inhibikase · Since at least Feb 14, 2025); Q32 Bio Inc. (Director · Since at least Mar 25, 2024); Third Harmonic Bio Inc. (Director · Since at least Sep 14, 2022); Akero Therapeutics Inc (Director · Since at least Jun 19, 2019); Kala Bio, Inc. (Director · Since at least Jul 19, 2017); Jade Biosciences, Inc. (Director · Apr 2, 2021 – Jun 5, 2024 · Past); Pulmatrix, Inc. (Director · Mar 20, 2017 – Jan 28, 2021 · Past) | Director · May 25, 2016 – Oct 10, 2020 · Past |
| Stephen George Dilly Other companies: Codexis, Inc. (Director · Since at least Jun 16, 2020); Sierra Oncology Inc (CEO and President, Director · Jun 1, 2020 – Jul 1, 2022 · Past); Sangamo Therapeutics, Inc. (Director · Jun 12, 2013 – May 18, 2020 · Past) | President and CEO, Director · Aug 5, 2015 – Jun 11, 2018 · Past |
| Brett K Haumann Other companies: Theravance Biopharma, Inc. (Chief Medical Officer · May 14, 2014 – Feb 20, 2021 · Past) | Director · Oct 31, 2018 – Oct 10, 2020 · Past |
| Stacey Denenberg Seltzer Other companies: OnKure Therapeutics, Inc. (Director · Apr 8, 2021 – Jun 6, 2023 · Past) | Director · Aug 5, 2015 – Oct 10, 2020 · Past |
| Daniel C Md Adelman | Chief Medical Officer · Jun 16, 2016 – Oct 10, 2020 · Past |
Log in to ask 6ix AI your own questions about Aimmune Therapeutics Inc.